Tissue collection for Head and Neck Cancers

N/A
Waitlist Available
Led By Terry Day, MD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up1 month (at the time of surgery)
Awards & highlights
No Placebo-Only Group

Study Summary

This trial is looking at whether changes in tissue, blood, and saliva samples can be linked to different clinical outcomes in patients.

Eligible Conditions
  • Head and Neck Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month (at the time of surgery)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month (at the time of surgery) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Count of patients who have research blood, saliva and tissue samples collected.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

5Treatment groups
Experimental Treatment
Group I: Young (<40 years old), Oral Cavity (Tongue) patientsExperimental Treatment4 Interventions
Blood, tissue and saliva specimen will be collected. Surveys will be administered.
Group II: Newly diagnosed, African American/Black, HPV negative, SmokingExperimental Treatment4 Interventions
Blood, tissue and saliva specimen will be collected. Surveys will be administered.
Group III: Neoadjuvant PD-1 Blockade patientsExperimental Treatment4 Interventions
Blood, tissue and saliva specimen will be collected. Surveys will be administered.
Group IV: Caucasian, HPV positive, Smoking patientsExperimental Treatment4 Interventions
Blood, tissue and saliva specimen will be collected. Surveys will be administered.
Group V: Caucasian, HPV positive, Non Smoking patientsExperimental Treatment4 Interventions
Blood, tissue and saliva specimen will be collected. Surveys will be administered.

Find a site

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
900 Previous Clinical Trials
5,364,958 Total Patients Enrolled
Terry Day, MDPrincipal Investigator
Medical University of South Carolina
Besim Ogretmen, PhDPrincipal Investigator
Medical University of South Carolina

Media Library

Tissue collection Clinical Trial Eligibility Overview. Trial Name: NCT03735745 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for new participants to join this research endeavor?

"The details posted on clinicaltrials.gov signify that this trial is not taking new applicants at present time, despite being initially listed on January 28th 2019 and amended most recently in August 9th 2022. Nonetheless, there are 548 other medical studies actively looking for patients to enroll."

Answered by AI
~0 spots leftby Oct 2023